knowledge -WSS

knowledge

author：comprehensive 2025-10-02 20:53:02 - browse：5558

Boston Globe

A commonly prescribed medication for children’s asthma is disappearing from pharmacists’ shelves, forcing parents and pediatricians to scramble for alternatives just as allergy season is about to start.

In a move unusual for such a widely used drug, GlaxoSmithKline discontinued Flovent HFA, the brand name of its corticosteroid treatment fluticasone propionate, at the end of December. Critics, including Massachusetts Senator Elizabeth Warren, say the decision helps the company avoid new Medicaid penalties going into effect this year for medications with price increases that outpace inflation.

“It was all very confusing, and we were left scrambling, trying to find out what we could do,” said Simone Fung, whose 5-year-old son, David, endured worse asthma symptoms over the past two months as the Cambridge family navigated confusing insurance policies and shortages of alternative medications to find a replacement for Flovent.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Future doctors need a strong humanities education

hotspot

Wikipedia

WSS

Prior authorization reform is both possible and imperative

Immunocompromised patients offer clues on chronic Covid

Moderna says combo Covid

5 takeaways from STAT's examination of Zynex Medical

Prior authorization reform is both possible and imperative

Coercive sterilizations revealed by STAT prompt outrage

knowledge

knowledge

explore

How one medical school became remarkably diverse

FDA endorses new sterilization method for medical devices

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

'Essentially witchcraft:' A former naturopath takes on the field

Guidelines to prevent youth baseball injuries need more muscle

Inaction leaves children at risk from dangerous chemotherapy drug

Virginia high school admissions case could be legal follow

Teladoc has a new CEO, but challenges remain the same

Anesthesiologist group: stop taking Ozempic before surgery

Deposition: Sackler embraced plan to conceal OxyContin’s strength

hotspot

Prior authorization reform is both possible and imperative

The inclusion problem at the heart of rehabilitation research

Flu vaccine reformulation won't be easy, manufacturers warn

The system is set up to fail children with medical complexity

Lilly's Alzheimer's drug donanemab backed by FDA advisers

The inclusion problem at the heart of rehabilitation research

hotspot

hotspot

Wikipedia

Wikipedia